Moreover, the anti-tumor efficacy of CAR-T cell was augmented by disrupting programmed cell death protein 1 (PD-1) 28, and the progeny of CAR-T cell through disruption of TET2 also effectively improved the therapeutic efficacy 29. Here, PDCD1 is linked to neoplasm.